1. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl. 1):S62-69.
3. Cosson E, Hamo-Tchatchouang E, Banu I, Nguyen MT, Chiheb S, Ba H, Valensi P. A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients. Diabetes Metab 2010;36:312-8.
4. Ryden L et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2013;34:3035-3087.
5. Paulweber B, Valensi P, Lindström J et al. A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes. Horm Metab Res 2010;S1: 3-36.
6. Cosson E, Chiheb S, Hamo-Tchatchouang E, Nguyen MT, Aout M, Banu I, Pillegand C, Vicaut E, Valensi P.Use of clinical scores to detect dysglycaemia in overweight or obese women. Diabetes Metab 2012;38 :217-224.
7. Bartnik M, Rydén L, Ferrari R et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004;25:1880-1890.
8. Vergès B, Avignon A, Bonnet F, Catargi B, Cattan S, Cosson E, Ducrocq G, Elbaz M, Fredenrich A, Gourdy P, Henry P, Lairez O, Leguerrier AM, Monpère C, Moulin P, Vergès-Patois B, Roussel R, Steg G, Valensi P. Consensus statement on the care of the hyperglycaemic/diabetic patient during and
in the immediate follow-up of acute coronary syndrome. Diabetes Metab 2012;38:113-127.
9. Vérier-Mine O. Outcomes in women with a history of gestational diabetes. Screening and prevention of type 2 diabetes. Literature review. Diabetes Metab 2010;36(6 Pt 2):595-616.
10. Bihan H, Cosson E, Khiter C, Vittaz L, Faghfouri F, Leboeuf D, Carbillon L, Dauphin H, Reach G, Valensi P. Factors associated with screening for glucose abnormalities after gestational diabetes mellitus: Baseline cohort of the interventional IMPACT study. Diabetes Metab 2014 Feb 3. [Epub ahead of print]
11. Gillies C, Abrams K, Lambert P, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007; 334:299.
Étude et pratique
HTA : quelle PA cible chez les patients à haut risque cardiovasculaire ?
Mise au point
Troubles psychiatriques : quand évoquer une maladie neurodégénérative ?
Étude et pratique
Complications de FA, l’insuffisance cardiaque plus fréquente que l’AVC
Cas clinique
L’ictus amnésique idiopathique